HEALTH 5 days ago Tuberculosis at the border: Doctors issue warnings of ‘drug-resistant strains’ Cases of tuberculosis, which kills more people than any other infectious disease, rose in the U.S. during 2022 — and some doctors are concerned that limitations of testing at the border could be partly to blame.
Hair Loss July 22 New hair loss treatments may be on the way after major discovery, researchers say Researchers from the University of California have identified a molecule called osteopontin that is linked to faster hair growth, a San Diego biopharmaceutical company has announced.
Media July 21 Detransitioned boy castrated by doctors warns kids about perils of gender ideology: 'Patient for life' A detransitioned 20-year-old who had castration surgery says he wants to warn young boys about following in his footsteps.
HEALTH July 20 Texas city reports syphilis outbreak amid 'limited supply' of penicillin drug As syphilis cases continue to spike across the U.S. — with some cities and states reporting outbreaks — there is growing concern about the availability of Bicillin to treat the infection.
HEALTH July 20 AI app helps aging adults manage their prescriptions with one photo: ‘Your personal health assistant’ “Together," a free iPhone app built on generative AI, is designed to help aging adults and their caregivers manage daily medications and other health care tasks. The creator shared insights.
HEALTH July 18 Dementia patients who take opioids face 'worrisome' death risk, new study finds A new study says that opioid use could put dementia patients at a higher risk of death. The research was recently revealed at the Alzheimer’s Association International Conference.
HEALTH July 18 New dementia drug 'has given me hope’: Alzheimer’s patients reveal their stories The first new Alzheimer’s treatment in 20 years was granted full FDA approval in early July 2023. Two patients who participated in the clinical trials share personal experiences.
DENTAL HEALTH July 15 'Dentist's dream' of regrowing teeth advances to clinical trials in Japan, says report Patients who haven't developed a full set of teeth due to genetics will be eligible, potentially, to participate in future clinical trials for experimental medicine to regrow teeth.
White House July 12 What is xylazine? White House launches national response plan for combating drug deaths The White House released a response plan this week to address the emerging threat of fentanyl combined with xylazine in the U.S. But, what is the drug and what are its effects?
HEALTH July 10 Ozempic diabetes and weight loss medication under investigation after a few reports of suicidal thoughts The popular medications Ozempic and Saxenda from Novo Nordisk are being investigated after three people experienced an increase in thoughts of suicide and self-harm.